Paper Details
- Home
- Paper Details
Design of the Trial to Assess Chelation Therapy (TACT).
Author: BoineauRobin, DriskoJeanne A, GoertzChristine, LamasGervasio A, LeeKerry L, MarkDaniel B, NahinRichard L, RozemaTheodore
Original Abstract of the Article :
TACT is an National Institutes of Health-sponsored, randomized, double-blind, placebo-controlled, 2 × 2 factorial clinical trial testing the benefits and risks of 40 infusions of a multicomponent disodium EDTA chelation solution compared with placebo and of an oral, high-dose multivitamin and minera...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/22172430
データ提供:米国国立医学図書館(NLM)
The Trial to Assess Chelation Therapy (TACT): Unveiling the Potential of Chelation Therapy
The field of cardiovascular health is constantly seeking novel therapies for preventing and treating heart disease. Chelation therapy, a procedure that removes heavy metals from the body, has been investigated for its potential benefits in cardiovascular health. This study, sponsored by the National Institutes of Health, is a large-scale clinical trial exploring the efficacy and safety of chelation therapy in patients with heart disease. The study design is rigorous, with a randomized, double-blind, placebo-controlled approach, and will follow a large cohort of patients for an average of four years. The primary endpoint is a composite measure of cardiovascular events, including mortality, heart attack, stroke, and hospitalization for angina.
The Potential of Chelation Therapy
This trial aims to provide definitive evidence on the effectiveness of chelation therapy in reducing cardiovascular risks. With a substantial sample size and a rigorous design, this study has the power to make a significant impact on how we approach cardiovascular health. If chelation therapy proves effective, it could revolutionize the way we prevent and treat heart disease, offering new hope to millions of people around the world.
Navigating Cardiovascular Health: A Desert of Knowledge
This research highlights the importance of rigorous scientific inquiry in exploring potential therapies for cardiovascular health. Chelation therapy's potential benefits are still under investigation, and it is crucial to approach this therapy with a critical eye, evaluating the evidence with a discerning mind. The results of this study will be crucial in shaping our understanding of chelation therapy and its role in cardiovascular care.
Dr.Camel's Conclusion
The TACT trial is a beacon of hope for those seeking new ways to combat heart disease. By rigorously evaluating chelation therapy, this study will provide valuable insights that could pave the way for better cardiovascular health in the future.
Date :
- Date Completed 2012-02-10
- Date Revised 2021-10-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.